Management to hold a conference call at 8:30 a.m. EDT
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable
medical robotics company that offers increased functionality for those
suffering from neurological disorders and upper limb paralysis, today
announced that it will release its financial results for the first
quarter ended March 31, 2019 on Monday, May 13, 2019, before the US
markets open.
The Company will host a conference call on Monday, May 13, 2019 at 8:30
a.m. EDT featuring remarks by Paul R. Gudonis, Chairman and Chief
Executive Officer, and David Henry, Chief Financial Officer. The
conference call, webcast can be accessed through Myomo’s Investor
Relations page. Please allow extra time prior to the call to visit
the site and download any necessary software to listen to the live
broadcast.
To dial into the conference call, please dial 1-877-270-2148 from the
U.S. or 1-412-902-6510 internationally. A replay of the conference call
will be available approximately one hour after completion of the live
conference call at the Investor
Relations page. A dial-in replay of the call will be available until
May 27, 2019; please dial 1-877-344-7529 from the U.S. or 1-412-317-0088
internationally and provide the passcode of 10130705.
About Myomo
Myomo, Inc. is a wearable medical robotics
company that offers expanded mobility for those suffering from
neurological disorders and upper limb paralysis. Myomo develops and
markets the MyoPro product line. MyoPro is a powered upper limb orthosis
designed to support the arm and restore function to the weakened or
paralyzed arms of patients suffering from CVA stroke, brachial plexus
injury, traumatic brain or spinal cord injury, ALS or other
neuromuscular disease or injury. It is currently the only marketed
device that, sensing a patient’s own EMG signals through non-invasive
sensors on the arm, can restore an individual’s ability to perform
activities of daily living, including feeding themselves, carrying
objects and doing household tasks. Many are able to return to work, live
independently and reduce their cost of care. Myomo is headquartered in
Cambridge, Massachusetts, with sales and clinical professionals across
the U.S. For more information, please visit www.myomo.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190507005148/en/
Copyright Business Wire 2019